-
1
-
-
0142210231
-
Pharmacotherapy of iron overload in thalassaemic patients
-
Ceci A, Felisi M, De Sanctis V, et al. 2003. Pharmacotherapy of iron overload in thalassaemic patients. Expert Opin Pharmacother, 4: 1763-74.
-
(2003)
Expert Opin Pharmacother
, vol.4
, pp. 1763-1774
-
-
Ceci, A.1
Felisi, M.2
de Sanctis, V.3
-
2
-
-
0026753162
-
Crystal structures of a new oral iron chelator, 1,2-dimethyl-3-hydroxy-4-pyridone, and its solvates with acetic acid and formic acid
-
Chan HK, Ghosh S, Venkataram S, et al. 1992. Crystal structures of a new oral iron chelator, 1,2-dimethyl-3-hydroxy-4-pyridone, and its solvates with acetic acid and formic acid. J Pharm Sci, 81:353-8.
-
(1992)
J Pharm Sci
, vol.81
, pp. 353-358
-
-
Chan, H.K.1
Ghosh, S.2
Venkataram, S.3
-
3
-
-
33747155184
-
Bonding
-
In Goldberg DL (ed, Singapore: McGraw Hill
-
Goldberg DL. 1989. Bonding. In Goldberg DL (ed). Chemistry. Singapore: McGraw Hill. p 95-118.
-
(1989)
Chemistry
, pp. 95-118
-
-
Goldberg, D.L.1
-
4
-
-
0038649860
-
Benefits and risks of deferiprone in iron overload in thalassaemia and other conditions: Comparison of epidemiological and therapeutic aspects with deferoxamine
-
Kontoghiorghes GJ, Neocleous K, Kolnagou A. 2003. Benefits and risks of deferiprone in iron overload in thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine. Drug Saf, 26:553-84.
-
(2003)
Drug Saf
, vol.26
, pp. 553-584
-
-
Kontoghiorghes, G.J.1
Neocleous, K.2
Kolnagou, A.3
-
5
-
-
3242753676
-
The design and development of deferiprone (L1) and other iron chelators for clinical use: Targeting methods and application prospects
-
Kontoghiorghes GJ, Pattichis K, Neocleous K, et al. 2004. The design and development of deferiprone (L1) and other iron chelators for clinical use: targeting methods and application prospects. Curr Med Chem, 11:2161-83.
-
(2004)
Curr Med Chem
, vol.11
, pp. 2161-2183
-
-
Kontoghiorghes, G.J.1
Pattichis, K.2
Neocleous, K.3
-
6
-
-
0041883805
-
Pathophysiology and treatment of iron overload in thalassemia patients in tropical countries
-
Marx JJ. 2003. Pathophysiology and treatment of iron overload in thalassemia patients in tropical countries. Adv Exp Med Biol, 531: 57-68.
-
(2003)
Adv Exp Med Biol
, vol.531
, pp. 57-68
-
-
Marx, J.J.1
-
7
-
-
0036304647
-
Orally active iron chelators
-
Merson L, Oliver N. 2002. Orally active iron chelators. Blood Rev, 16: 127-34.
-
(2002)
Blood Rev
, vol.16
, pp. 127-134
-
-
Merson, L.1
Oliver, N.2
-
8
-
-
13844306520
-
Enrichment of ligands for the serotonin receptor using the Shape Signatures approach
-
Nagarajan K, Zauhar R, Welsh WJ. 2005. Enrichment of ligands for the serotonin receptor using the Shape Signatures approach. J Chem Inf Model, 45:49-57.
-
(2005)
J Chem Inf Model
, vol.45
, pp. 49-57
-
-
Nagarajan, K.1
Zauhar, R.2
Welsh, W.J.3
-
9
-
-
0038663096
-
Iron chelator research: Past, present, and future
-
Tam TF, Leung-Toung R, Li W, et al. 2003. Iron chelator research: past, present, and future. Curr Med Chem, 10:983-95.
-
(2003)
Curr Med Chem
, vol.10
, pp. 983-995
-
-
Tam, T.F.1
Leung-Toung, R.2
Li, W.3
-
10
-
-
84870201373
-
Deferiprone-iron complex in chelation: Generation of a three dimensional model
-
In press
-
Wiwanitkit V. 2005 Deferiprone-iron complex in chelation: generation of a three dimensional model. Haema. In press.
-
(2005)
Haema
-
-
Wiwanitkit, V.1
|